During the past decade, UH Seidman Cancer Center at Landerbrook Health Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 19 clinical trials were completed, i.e. on average, 79.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 17 clinical trials were completed. i.e. 212.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UH Seidman Cancer Center at Landerbrook Health Center" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Case Comprehensive Cancer Center" with 8 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UH Seidman Cancer Center at Landerbrook Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "UH Seidman Cancer Center at Landerbrook Health Center" are "Breast Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Invasive Breast Carcinoma" (3 trials) and "Recurrent Ovarian Carcinoma" (3 trials). Many other conditions were trialed in "UH Seidman Cancer Center at Landerbrook Health Center" in a lesser frequency.

Most popular intervention types in "UH Seidman Cancer Center at Landerbrook Health Center" are "Drug" (34 trials), "Other" (29 trials), "Biological" (16 trials), "Procedure" (8 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (9 trials), "Carboplatin" (6 trials), "Cisplatin" (6 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "UH Seidman Cancer Center at Landerbrook Health Center" are 31 trials for "All" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "UH Seidman Cancer Center at Landerbrook Health Center". undefined are not yet recruiting, 7 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in UH Seidman Cancer Center at Landerbrook Health Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UH Seidman Cancer Center at Landerbrook Health Center, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".